Aspecta | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Background information on the study | 47 (65%) | 24 (33%) | 1 (1%) | 0 (0%) | 0 (0%) |
Informed consent | 47 (65%) | 24 (33%) | 0 (0%) | 1 (1%) | 0 (0%) |
Participant eligibility | 40 (56%) | 27 (38%) | 5 (7%) | 0 (0%) | 0 (0%) |
Participants' needs receiving information | 38 (53%) | 29 (40%) | 5 (7%) | 0 (0%) | 0 (0%) |
Information specific to the trial topic area | 37 (51%) | 35 (49%) | 0 (0%) | 0 (0%) | 0 (0%) |
Recruitment challenges | 35 (49%) | 32 (45%) | 4 (6%) | 0 (0%) | 0 (0%) |
Recruitment pathways | 34 (48%) | 32 (45%) | 5 (7%) | 0 (0%) | 0 (0%) |
Recruitment materials | 33 (46%) | 35 (49%) | 4 (6%) | 0 (0%) | 0 (0%) |
Randomisation | 32 (45%) | 34 (48%) | 3 (4%) | 2 (3%) | 0 (0%) |
Completing trial documentation | 32 (44%) | 29 (40%) | 10 (14%) | 1 (1%) | 0 (0%) |
Participants' treatment options | 31 (44%) | 32 (45%) | 8 (11%) | 0 (0%) | 0 (0%) |
Equipoise | 31 (43%) | 34 (47%) | 5 (7%) | 2 (3%) | 0 (0%) |
Blinding | 26 (36%) | 34 (47%) | 9 (13%) | 2 (3%) | 1 (1%) |
Bio samples | 25 (35%) | 30 (42%) | 9 (13%) | 6 (8%) | 2 (3%) |
General information on trials | 22 (31%) | 40 (57%) | 3 (4%) | 4 (6%) | 1 (1%) |
Management of the trial team | 22 (31%) | 32 (46%) | 11 (16%) | 5 (7%) | 0 (0%) |